This grant, offered by the National Institutes of Health, is designed to fund hypothesis-driven clinical research focused on identifying new diagnostic, prognostic, or therapeutic biomarkers for Lewy Body Dementias (LBD). Successful projects must involve research conducted directly in LBD patients. A critical requirement is adherence to the established Parkinson’s Disease Biomarker Program (PDBP) protocols for both clinical assessment and the collection of biospecimens. Furthermore, all generated biomarker research data and biospecimens must be made broadly shareable through the PDBP repositories. This ensures the wider scientific community benefits from the findings, accelerating advancements in understanding and treating LBD.
Opportunity ID: 335141
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-NS-22-001 |
Funding Opportunity Title: | Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 06, 2021 |
Last Updated Date: | Aug 06, 2021 |
Original Closing Date for Applications: | Nov 22, 2021 |
Current Closing Date for Applications: | Nov 22, 2021 |
Archive Date: | Dec 28, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Native American tribal governments (Federally recognized) State governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this funding opportunity announcement (FOA) is to support hypothesis-driven clinical research applications that are focused on discovering novel diagnostic, prognostic, and/or therapeutic biomarkers for the Lewy Body Dementias (LBD).Biomarker research must be conducted in patients with LBD, must follow Parkinson’s Disease Biomarker Program (PDBP) protocols for clinical assessment and biospecimen collection,and must be broadly shareable through the PDBP repositories. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-001.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268469 | Sep 22, 2021 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270439 | Nov 18, 2021 | Nov 22, 2021 | View |
Package 1
Mandatory forms
335141 RR_SF424_2_0-2.0.pdf
335141 PHS398_CoverPageSupplement_5_0-5.0.pdf
335141 RR_OtherProjectInfo_1_4-1.4.pdf
335141 PerformanceSite_2_0-2.0.pdf
335141 RR_KeyPersonExpanded_2_0-2.0.pdf
335141 PHS398_ResearchPlan_4_0-4.0.pdf
335141 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335141 RR_Budget_1_4-1.4.pdf
335141 RR_SubawardBudget30_1_4-1.4.pdf
335141 PHS398_ModularBudget_1_2-1.2.pdf
335141 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335141 RR_SF424_5_0-5.0.pdf
335141 PHS398_CoverPageSupplement_5_0-5.0.pdf
335141 RR_OtherProjectInfo_1_4-1.4.pdf
335141 PerformanceSite_4_0-4.0.pdf
335141 RR_KeyPersonExpanded_4_0-4.0.pdf
335141 PHS398_ResearchPlan_4_0-4.0.pdf
335141 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335141 RR_Budget_3_0-3.0.pdf
335141 RR_SubawardBudget30_3_0-3.0.pdf
335141 PHS398_ModularBudget_1_2-1.2.pdf
335141 PHS_AssignmentRequestForm_3_0-3.0.pdf